Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M211,578Revenue $M49,605Net Margin (%)18.7Altman Z-Score2.8
Enterprise Value $M220,106EPS $1.4Operating Margin %25.9Piotroski F-Score6
P/E(ttm)23.8Beneish M-Score-2.7Pre-tax Margin (%)25.4Higher ROA y-yN
Price/Book3.210-y EBITDA Growth Rate %2.6Quick Ratio2.2Cash flow > EarningsY
Price/Sales4.55-y EBITDA Growth Rate %4.4Current Ratio2.5Lower Leverage y-yN
Price/Free Cash Flow17.1y-y EBITDA Growth Rate %-9.8ROA % (ttm)5.4Higher Current Ratio y-yY
Dividend Yield %3.1PEG5.3ROE % (ttm)12.4Less Shares Outstanding y-yY
Payout Ratio %73.0Shares Outstanding M6,158ROIC % (ttm)12.1Gross Margin Increase y-yN

Gurus Latest Trades with PFE

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PFEKahn Brothers 2015-03-31 Reduce-0.39%$31.16 - $35.05
($33.51)
$ 34.363%Reduce 3.83%1,811,016
PFEJames Barrow 2015-03-31 Reduce-0.32%$31.16 - $35.05
($33.51)
$ 34.363%Reduce 12.24%55,080,222
PFENWQ Managers 2015-03-31 Reduce-0.16%$31.16 - $35.05
($33.51)
$ 34.363%Reduce 6.64%5,927,532
PFEJoel Greenblatt 2015-03-31 Add0.15%$31.16 - $35.05
($33.51)
$ 34.363%Add 38.84%1,972,788
PFECharles Brandes 2015-03-31 Reduce-0.07%$31.16 - $35.05
($33.51)
$ 34.363%Reduce 2.37%6,123,536
PFEDavid Dreman 2015-03-31 Add0.03%$31.16 - $35.05
($33.51)
$ 34.363%Add 70.38%25,202
PFEMario Gabelli 2015-03-31 Reduce-0.01%$31.16 - $35.05
($33.51)
$ 34.363%Reduce 5.80%896,431
PFEDodge & Cox 2015-03-31 Reduce-0.01%$31.16 - $35.05
($33.51)
$ 34.363%Reduce 0.89%46,776,959
PFERichard Pzena 2015-03-31 Reduce$31.16 - $35.05
($33.51)
$ 34.363%Reduce 0.50%2,159,618
PFEFirst Eagle Investment 2015-03-31 Reduce$31.16 - $35.05
($33.51)
$ 34.363%Reduce 0.12%5,266,820
PFEJohn Keeley 2015-03-31 Reduce$31.16 - $35.05
($33.51)
$ 34.363%Reduce 1.27%98,689
PFEKen Fisher 2015-03-31 Add$31.16 - $35.05
($33.51)
$ 34.363%Add 0.04%31,208,271
PFEKahn Brothers 2014-12-31 Reduce-0.49%$27.7 - $32.09
($30.23)
$ 34.3614%Reduce 5.14%1,883,217
PFEFirst Eagle Investment 2014-12-31 Add0.39%$27.7 - $32.09
($30.23)
$ 34.3614%Add 3786.85%5,272,943
PFERichard Pzena 2014-12-31 Buy 0.36%$27.7 - $32.09
($30.23)
$ 34.3614%New holding2,170,568
PFEVanguard Health Care Fund 2014-12-31 Add0.32%$27.7 - $32.09
($30.23)
$ 34.3614%Add 29.88%19,395,622
PFEMichael Price 2014-12-31 Sold Out -0.17%$27.7 - $32.09
($30.26)
$ 34.3614%Sold Out0
PFEKahn Brothers 2014-09-30 Reduce-0.59%$28.04 - $30.96
($29.58)
$ 34.3616%Reduce 6.56%1,985,161
PFEMichael Price 2014-09-30 Reduce-0.22%$28.04 - $30.96
($29.58)
$ 34.3616%Reduce 56.02%47,100
PFEFirst Eagle Investment 2014-09-30 Reduce-0.16%$28.04 - $30.96
($29.58)
$ 34.3616%Reduce 94.11%135,661
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PFE is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PFE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SUSMAN SALLYExecutive Vice President 2015-03-12Sell46,179$34-1.38view
READ IAN CChairman & CEO 2015-03-05Sell67,500$34.62-3.15view
Dolsten MikaelPresident R&D 2015-03-05Sell58,298$34.46-2.7view
CANGIALOSI LORETTA VSr. Vice President, Controller 2015-02-13Sell104,000$34.73-3.46view
MADDALUNA ANTHONY JExecutive Vice President 2015-02-12Sell9,000$34.85-3.79view
DAMELIO FRANK AExecutive Vice President 2015-02-11Sell80,200$34.23-2.04view
DAMELIO FRANK AExecutive Vice President 2015-02-11Sell14,800$34.3-2.24view
MADDALUNA ANTHONY JExecutive Vice President 2015-02-10Sell9,000$33.78-0.74view
MADDALUNA ANTHONY JExecutive Vice President 2014-12-08Sell6,500$324.78view
HILL CHARLES HExecutive Vice President 2014-11-10Sell8,285$30.1811.1view

Press Releases about PFE :

    Quarterly/Annual Reports about PFE:

      News about PFE:

      Articles On GuruFocus.com
      Endo International Posts Upbeat Q1 Results May 13 2015 
      Bayer Enters Into Collaboration With Isis For Enhancing Its Drug Portfolio May 07 2015 
      Pfizer is a Good Buy Post Recent Results May 03 2015 
      Biogen Making A Breakthrough In Treating Alzheimer’s May 02 2015 
      Crouching Tigers, Hidden Assets – Smead Capital Management Apr 30 2015 
      Currency Woes Impact Pfizer Sales In Q1, Management Lowers Future Guidance Apr 29 2015 
      Pfizer On The Mission Of Developing Life-Saving Cancer Drugs Apr 22 2015 
      John Rogers' Ariel Fund Q1 2015 Commentary Apr 16 2015 
      Can a Strong U.S. Dollar Increase or Decrease the Value of Global Currencies? Apr 16 2015 
      Are U.S. Investors Showing Confidence in the Stock Market? Apr 16 2015 

      More From Other Websites
      An Attractive M&A Play In The Busy Biotech Space May 13 2015
      10 Important Checkpoint Inhibitor Cancer Drug Abstracts from ASCO '15 May 13 2015
      Merck KGaA, Darmstadt, Germany, and Pfizer to Present Data at ASCO for Avelumab, an Investigational... May 13 2015
      Merck and Pfizer to Present Data at ASCO for Avelumab, an Investigational Anti-PD-L1 Antibody May 13 2015
      Merck KGaA, Darmstadt, Germany, and Pfizer to Present Data at ASCO for Avelumab, an Investigational... May 13 2015
      AstraZeneca drug combination on track to fight lung cancer May 13 2015
      Pfizer drug shows early promise in Xalkori-resistant lung cancer-study May 13 2015
      The 4 Stocks That Drove the DJIA Down on Wednesday May 13 2015
      Hospira Shareholders Approve Merger of Hospira and Pfizer at Special Meeting May 13 2015
      PFIZER INC Financials May 13 2015
      Biotech investors: These are the key names to know May 13 2015
      5 New Biotech Developments Worth Watching May 13 2015
      Possible Investment Contest May 13 2015
      How DNA sequencing is transforming the hunt for new drugs May 13 2015
      Pfizer Acquires Stake in Dutch Biopharmaceutical Company - Analyst Blog May 12 2015
      Pfizer Buys a Minority Stake in Dutch Biotech Firm AM-Pharma May 12 2015
      Pfizer Buys a Minority Stake in Dutch Biotech Firm AM-Pharma May 12 2015
      US stocks drop as bond yields spike May 12 2015
      Short Sellers Keep Strong Bets Against Big Pharma May 12 2015
      Pharmalot.. Pharmalittle.. Good Morning: We're Catching up on Mylan, Teva and Much More!! May 12 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      SEENSCO
      ReplySEENSCO - 11 months ago
      PFE is trading at the low end of our short-term valuation range ($29-$36) and significantly below our Fair Value estimate of $42.41.
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      FEEDBACK